Dr Kathryn Field

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone 0412 568 539

Map

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Field, K., Zalcberg, J. (2010). Chemotherapy: Metastatic Disease. In Czito B; Willett C (Eds.), Rectal Cancer: International Perspectives on Multimodality Management, (pp. 189-222). United States: Springer Science + Business Media.
  • Field, K., Phillips, K. (2010). Management of Women at High Familial Risk of Breast and Ovarian Cancer. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 941-967). London: Imperial College Press.

Journals

  • Tran, B., Keating, C., Ananda, S., Kosmider, S., Jones, I., Croxford, M., Field, K., Carter, R., Gibbs, P. (2012). Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data. Internal Medicine Journal, 42(7), 794-800. [More Information]
  • Field, K., Faragher, I., Gibbs, P. (2011). Bending the cost curve in cancer care. The New England Journal of Medicine, 365(7), 675-676. [More Information]
  • Field, K., Zalcberg, J. (2011). Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies. Current Colorectal Cancer Reports, 7(3), 227-240. [More Information]
  • Field, K., Rosenthal, M., Dimou, J., Fleet, M., Gibbs, P., Drummond, K. (2011). Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology. Journal of Clinical Neuroscience, 17(9), 1130-1135. [More Information]
  • Field, K., Zelenko, A., Kosmider, S., Court, K., NG, L., Hibbert, M., Gibbs, P. (2011). Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs. Asia-Pacific Journal of Clinical Oncology, 6(3), 203-209. [More Information]
  • Field, K., McFarlane, C., Cheng, A., Hughes, A., Jacobs, E., Styles, K., Low, J., Stow, P., Campbell, P., Athan, E. (2011). Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infection Control and Hospital Epidemiology, 28(5), 610-613. [More Information]
  • Field, K., Kosmider, S., Johns, J., Farrugia, H., Hastie, I., Croxford, M., Chapman, M., Harold, M., Murigu, N., Gibbs, P. (2011). Linking data from hospital and cancer registry databases: should this be standard practice? Internal Medicine Journal, 40(8), 566-573. [More Information]
  • Field, K., Michael, M., Leong, T. (2011). Locally advanced and metastatic gastric cancer: current management and new treatment developments. Drugs, 68(3), 299-317. [More Information]
  • Field, K., Platell, C., Rieger, N., Skinner, I., Wattchow, D., Jones, I., Chen, F., Kosmider, S., Wohlers, T., Hibbert, M., et al (2011). Lymph node yield following colorectal cancer surgery. ANZ Journal of Surgery, 81(4), 266-271. [More Information]
  • Field, K., Campbell, B., DE BOER, R. (2011). Male breast cancer: Progress, prognosis and future pathways. Asia-Pacific Journal of Clinical Oncology, 4(1), 6-17. [More Information]
  • Field, K., Lipton, L. (2011). Metastatic colorectal cancer-past, progress and future. World Journal of Gastroenterology, 13(28), 3806-3815. [More Information]
  • Field, K., Dow, C., Michael, M. (2011). Part I: Liver function in oncology: biochemistry and beyond. The Lancet Oncology, 9(11), 1092-1101. [More Information]
  • Field, K., Michael, M. (2011). Part II: Liver function in oncology: towards safer chemotherapy use. The Lancet Oncology, 9(12), 1181-1190. [More Information]
  • Kosmider, S., Stella, D., Field, K., Moore, M., Ananda, S., Oakman, C., Singh, M., Gibbs, P. (2011). Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice? Colorectal Disease: The official journal of the Association of Coloproctology of Great Britain and Ireland, 11(6), 592-600. [More Information]
  • Kosmider, S., Field, K., Jefford, M., Jennens, R., Gibbs, P. (2011). Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists? Internal Medicine Journal, 38(6), 415-421. [More Information]
  • Field, K., Desai, J. (2011). Targeted therapies for sarcomas (including gastrointestinal stromal tumours). Cancer Forum, 32(3), 1-7.
  • Moore, M., Desai, J., Croxford, M., Field, K., Hastie, I., Gibbs, P. (2010). Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes. Journal of Clinical Oncology, 28(3), e36-7; author reply e38. [More Information]
  • Field, K., Croxford, M., Hastie, I., Chen, F., Kosmider, S., Desai, J., Gibbs, P. (2009). Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data. Journal of Clinical Oncology, 27(9), 1524-1526. [More Information]
  • Field, K., Jenkins, M., Friedlander, M., McKinley, J., Price, M., Weideman, P., Keogh, L., McLachlan, S., Lindeman, G., Hopper, J., Butow, P., et al (2009). Predictors of the use of Complementary and Alternative Medicine (CAM) by women at high risk for breast cancer. European Journal of Cancer, 45(4), 551-560. [More Information]
  • Moore, M., Kosmider, S., Field, K., Desai, J., Lim, L., Barnett, F., Gibbs, P. (2009). Response to Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".". The Oncologist, 14(1), 104-5; author reply 106-7. [More Information]
  • Kosminder, S., Field, K., Jefford, M., Gibbs, P. (2008). Anticoagulation prophylaxis for central venous catheter-associated thrombosis in cancer patients: An Australian perspective. Asia-Pacific Journal of Clinical Oncology, 4(1), 2-5. [More Information]
  • Field, K., Phillips, K. (2007). Management of women at high familial risk for breast and ovarian cancer. Cancer Forum, 31(3), 141-149.

2012

  • Tran, B., Keating, C., Ananda, S., Kosmider, S., Jones, I., Croxford, M., Field, K., Carter, R., Gibbs, P. (2012). Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data. Internal Medicine Journal, 42(7), 794-800. [More Information]

2011

  • Field, K., Faragher, I., Gibbs, P. (2011). Bending the cost curve in cancer care. The New England Journal of Medicine, 365(7), 675-676. [More Information]
  • Field, K., Zalcberg, J. (2011). Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies. Current Colorectal Cancer Reports, 7(3), 227-240. [More Information]
  • Field, K., Rosenthal, M., Dimou, J., Fleet, M., Gibbs, P., Drummond, K. (2011). Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology. Journal of Clinical Neuroscience, 17(9), 1130-1135. [More Information]
  • Field, K., Zelenko, A., Kosmider, S., Court, K., NG, L., Hibbert, M., Gibbs, P. (2011). Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs. Asia-Pacific Journal of Clinical Oncology, 6(3), 203-209. [More Information]
  • Field, K., McFarlane, C., Cheng, A., Hughes, A., Jacobs, E., Styles, K., Low, J., Stow, P., Campbell, P., Athan, E. (2011). Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infection Control and Hospital Epidemiology, 28(5), 610-613. [More Information]
  • Field, K., Kosmider, S., Johns, J., Farrugia, H., Hastie, I., Croxford, M., Chapman, M., Harold, M., Murigu, N., Gibbs, P. (2011). Linking data from hospital and cancer registry databases: should this be standard practice? Internal Medicine Journal, 40(8), 566-573. [More Information]
  • Field, K., Michael, M., Leong, T. (2011). Locally advanced and metastatic gastric cancer: current management and new treatment developments. Drugs, 68(3), 299-317. [More Information]
  • Field, K., Platell, C., Rieger, N., Skinner, I., Wattchow, D., Jones, I., Chen, F., Kosmider, S., Wohlers, T., Hibbert, M., et al (2011). Lymph node yield following colorectal cancer surgery. ANZ Journal of Surgery, 81(4), 266-271. [More Information]
  • Field, K., Campbell, B., DE BOER, R. (2011). Male breast cancer: Progress, prognosis and future pathways. Asia-Pacific Journal of Clinical Oncology, 4(1), 6-17. [More Information]
  • Field, K., Lipton, L. (2011). Metastatic colorectal cancer-past, progress and future. World Journal of Gastroenterology, 13(28), 3806-3815. [More Information]
  • Field, K., Dow, C., Michael, M. (2011). Part I: Liver function in oncology: biochemistry and beyond. The Lancet Oncology, 9(11), 1092-1101. [More Information]
  • Field, K., Michael, M. (2011). Part II: Liver function in oncology: towards safer chemotherapy use. The Lancet Oncology, 9(12), 1181-1190. [More Information]
  • Kosmider, S., Stella, D., Field, K., Moore, M., Ananda, S., Oakman, C., Singh, M., Gibbs, P. (2011). Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice? Colorectal Disease: The official journal of the Association of Coloproctology of Great Britain and Ireland, 11(6), 592-600. [More Information]
  • Kosmider, S., Field, K., Jefford, M., Jennens, R., Gibbs, P. (2011). Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists? Internal Medicine Journal, 38(6), 415-421. [More Information]
  • Field, K., Desai, J. (2011). Targeted therapies for sarcomas (including gastrointestinal stromal tumours). Cancer Forum, 32(3), 1-7.

2010

  • Field, K., Zalcberg, J. (2010). Chemotherapy: Metastatic Disease. In Czito B; Willett C (Eds.), Rectal Cancer: International Perspectives on Multimodality Management, (pp. 189-222). United States: Springer Science + Business Media.
  • Field, K., Phillips, K. (2010). Management of Women at High Familial Risk of Breast and Ovarian Cancer. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 941-967). London: Imperial College Press.
  • Moore, M., Desai, J., Croxford, M., Field, K., Hastie, I., Gibbs, P. (2010). Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes. Journal of Clinical Oncology, 28(3), e36-7; author reply e38. [More Information]

2009

  • Field, K., Croxford, M., Hastie, I., Chen, F., Kosmider, S., Desai, J., Gibbs, P. (2009). Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data. Journal of Clinical Oncology, 27(9), 1524-1526. [More Information]
  • Field, K., Jenkins, M., Friedlander, M., McKinley, J., Price, M., Weideman, P., Keogh, L., McLachlan, S., Lindeman, G., Hopper, J., Butow, P., et al (2009). Predictors of the use of Complementary and Alternative Medicine (CAM) by women at high risk for breast cancer. European Journal of Cancer, 45(4), 551-560. [More Information]
  • Moore, M., Kosmider, S., Field, K., Desai, J., Lim, L., Barnett, F., Gibbs, P. (2009). Response to Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".". The Oncologist, 14(1), 104-5; author reply 106-7. [More Information]

2008

  • Kosminder, S., Field, K., Jefford, M., Gibbs, P. (2008). Anticoagulation prophylaxis for central venous catheter-associated thrombosis in cancer patients: An Australian perspective. Asia-Pacific Journal of Clinical Oncology, 4(1), 2-5. [More Information]

2007

  • Field, K., Phillips, K. (2007). Management of women at high familial risk for breast and ovarian cancer. Cancer Forum, 31(3), 141-149.

To update your profile click here. For support on your academic profile contact .